The Point of Care Testing (POCT) market is on track to nearly double in size, projected to reach USD 56.5 billion by 2035, driven by rapid advancements in diagnostic technology and an increasing demand for immediate healthcare solutions.
The global POCT market is forecasted to grow from USD 26.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. This surge is attributed to the rising prevalence of chronic and infectious diseases, the shift towards decentralized healthcare, and innovations in portable diagnostic devices. POCT allows for swift and accurate results in various settings, including hospitals, clinics, and even home care, thereby enhancing clinical decision-making.
Technological advancements such as molecular diagnostics, AI-enabled platforms, and smartphone integration are reshaping the POCT landscape. The increasing burden of diseases like diabetes, cardiovascular issues, and infections is prompting greater adoption of these testing methods. Moreover, government initiatives aimed at early disease detection and preventive care are creating substantial opportunities for healthcare providers and manufacturers alike.
North America currently leads the market, supported by robust healthcare infrastructure and high spending. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth, driven by modernization and government efforts to enhance diagnostic access. The ongoing integration of digital health technologies and AI into POCT devices is set to further transform patient management and accessibility in healthcare systems globally.